WebCowen Prime Advisors LLC is a registered investment firm that has its headquarters in New York, New York. The investment advisory business has just four financial advisors. It handles $366 million in total assets across its 75 customer accounts, placing it among the bigger financial advisory firms in the nation by assets under management. ... WebCowen Prime Advisors LLC (CRD# 315686) is a financial advisory firm headquartered in New York, NY. They manage $365,829,521 in 75 accounts and serve the financial needs …
GSI Technology (NASDAQ:GSIT) Earns Hold Rating from Analysts …
WebApr 12, 2024 · Cowen Prime Advisors LLC grew its holdings in shares of Synchronoss Technologies by 459.6% during the fourth quarter. Cowen Prime Advisors LLC now owns 64,349 shares of the software maker’s ... WebCowen Prime Advisors LLC administers all of the company's client assets in a discretionary manner. Discretionary management is a structure in which a portfolio manager makes buy and sell judgments for the client's account without needing to seek the customer's permission. The investment advisory firm's typical account size is $4.9 million. richard franco
COWEN PRIME ADVISORS LLC Top 13F Holdings
WebAs of 25th January 2024, Cowen Prime Advisors’s top holding is 1,431,404 shares of PDF Solutions currently worth over $40.8 million and making up 16.8% of the portfolio value. Relative to the number of outstanding shares of PDF Solutions, Cowen Prime Advisors owns more than approximately 0.1% of the company. In addition, the fund holds ... WebMar 27, 2024 · Firm Details for COWEN PRIME ADVISORS LLC, Location: New York, AUM = 345388040.00, Last Form ADV Filed : 27-March-2024, Officers: JORDAN, FRANCIS, Potenciano, Joel, Kasunuran, COWEN PB HOLDINGS LLC RADiENT dramatically simplifies identifying and analyzing funds, researching investment advisers and creating … WebCowen Prime Advisors is a large advisory firm with 75 clients and discretionary assets under management (AUM) of $365,829,521 (Form ADV from 2024-07-11). Their last … richard francis novartis